Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin in Acute Kawasaki Disease
jRCTs031180057Phase 1Completed
- Sponsor
- National Center for Child Health and Development
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of atorvastatin in Kawasaki disease (KD) and coronary artery anomalies (CAA), sponsored by National Center for Child Health and Development. Primary endpoint: Safety of atorvastatin in the study population. Started Oct 2019; status: completed.
02
Drugs
atorvastatin
03
Conditions
Kawasaki disease (KD)coronary artery anomalies (CAA)
Beyond the preview
Go deeper on jRCTs031180057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180057.